|
⚲
|
| Keyboard |
| Clarus Ventures LLC
✚
|
|
|---|---|
| CRD # | 160980 |
| SEC # | 801-114471 |
| CIK # | 0001431431 |
| AUM | 805.6 M (2026-03-30) |
| Employees | 31 (68% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 617-949-2200 |
| Address | 314 Main St Cambridge, MA 02142 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Facebook] [Instagram] |
| Total AUM ($B) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/30/2026) [Brochure] |
|---|
Item 5 – Fees and Compensation Management Fees and Performance Fees Per the Advisory Agreements with each of the Funds, the Clarus Adviser is entitled to compensation for its services in the form of a management fee (the “Management Fee”), generally payable quarterly in advance. The Management Fee is based on either committed capital or invested capital, depending on the Fund and whether its investment period is currently active. Prorated refunds would be provided for partial quarters, if any, to the extent applicable. As set forth in Item 6 below, the General Partner of each Fund is also eligible to receive performance-based or “carried interest” allocations. The Confidential Private Placement Memorandum (as supplemented from time to time) and the Partnership Agreement and Advisory Agreements (collectively, the “Organizational Documents”) of each Fund include further details on fees and compensation and related matters. Management Fees and performance-based allocations are either withheld from distributions or, in the case of Management Fees, invoiced at an appropriate time pursuant to a capital call notice. Certain investors in the Funds, including current and/or former senior/executive/operating or other advisors, officers, directors and personnel of Blackstone and/or other key advisors/relationships (including operating partners, executives, founders and entrepreneurs), Portfolio Entities (as defined herein) of the Funds and Other Blackstone Clients (as defined herein), including charitable programs, endowment funds and related entities established by or associated with any of the foregoing (including any trusts, family members, family investment vehicles, estate planning vehicles, descendants, trusts and other related persons or entities), and other persons related to Blackstone (“Blackstone Investors”), will not pay Management Fees and/or performance-based or carried interest allocations in connection with their investment in or alongside the Funds or Blackstone-sponsored funds that make investments in the Funds. Notwithstanding the foregoing, such investors will either directly pay for their pro rata share of certain Fund expenses (as described below), or the pro rata amount of such expenses will be allocated to the applicable General Partner or its affiliates. Such pro rata allocation of Fund expenses will, in certain circumstances, be calculated based on capital commitments, invested capital, available capital or other metrics as determined by the applicable General Partner or its affiliates in its sole discretion. Any such methodology (including the choice thereof) involves inherent conflicts and will, in certain circumstances, not result in perfect attribution and allocation of expenses. In addition, to the extent current and/or former partners, employees, advisors and other persons referred to above, including their charitable programs, endowment funds and related entities established by or associated with any of the foregoing (including any trusts, family members, family investment vehicles, estate planning vehicles, descendants, trusts and other related persons and entities), make capital commitments and/or otherwise invest in or alongside the Funds, any such amounts will in certain circumstances, in the General Partner’s sole discretion, be treated as satisfying the applicable portion of any required capital commitment of the General Partners and/or their affiliates to the Funds , as applicable (even in circumstances where any such commitments or investments are made following a separation from Blackstone). For more information with respect to the allocation of Fund expenses, please see “—Expenses” in this Item 5 below. Blackstone Strategic Relationships. Blackstone has entered, and it can be expected that Blackstone in the future will enter, into strategic relationships with investors (and/or one or more of their affiliates) that involve an overall relationship with Blackstone that could (but is not required to) incorporate one or more strategies (including, but not limited to, a different sector and/or geographic focus within the same or a different Blackstone business unit) in addition to the Funds’ strategies (“Strategic Relationships”). A Strategic Relationship often involves (but is not required to involve) an investor agreeing to make a capital commitment or extend a commitment or lock-up period, as applicable, to two or more Blackstone vehicles, one of which could be a Fund. To the fullest extent permitted by law, Investors in the Funds will not receive a copy of any agreement memorializing a Strategic Relationship program (even if in the form of a side letter) or receive any other disclosure or reporting of the terms of or existence of any Strategic Relationship and will be unable to elect in the “most-favored nations” election process any rights or benefits afforded through a Strategic Relationship (and, for the avoidance of doubt, it is not expected that any further disclosure or reporting information will be shared with the limited partners about any Strategic Relationship except as may be required by law). Specific examples of such additional rights and benefits have included and can be expected to include, among others, specialized reporting, secondment arrangements discounts or reductions on and/or reimbursements or rebates of management fees or carried interest, secondment of personnel from the investor to Blackstone (or vice versa), targeted amounts for co-investment opportunities alongside Blackstone vehicles (including without limitation, preferential or favorable allocation of co-investment opportunities), and preferential terms and conditions related to co-investment or other participation in Blackstone vehicles (including any carried interest and/or Management Fees to be charged with respect thereto, as well as any additional discounts, reductions, reimbursements or rebates thereof or other penalties that ... |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/30/2026) [Brochure] |
|---|
Item 7 – Types of Clients The Clarus Adviser manages the Funds. The Funds’ investors consist of some or all of the following: Insurance companies Public and private retirement and pension plans Trusts and estates Charitable organizations and foundations, including endowment funds thereof State and municipal government agencies Private investment funds Corporations Business entities other than those listed above High net worth individuals Family offices All investors are subject to applicable suitability requirements. The Clarus Adviser and the General Partners require that each investor in the Funds be (i) an “accredited investor” as defined in Regulation D under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and (ii) a “qualified purchaser” as defined in Section 2(a)(51) of the U.S. Investment Company Act of 1940, as amended (the “1940 Act”), and meet other suitability requirements (including, in some circumstances, a person that is not a U.S. Person as defined in Regulation S under the Securities Act). Generally, investors must invest a minimum dollar amount as determined in the applicable General Partner’s sole discretion. Each General Partner reserves the right, in its sole discretion, to waive the minimum dollar amount. |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Clarus IV-A LP | [2018-03-28] | 789.7 M | 217.3 M |
| Offered $880,000,000 · Filed 2017-05-17 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $100,000 · Remaining $90,300,000 · Duration One year or less · Commission $4,400,000 · Revenue Not Applicable | ||||
| VC | Clarus IV-B LP | [2018-03-28] | 789.7 M | 139.5 M |
| Offered $880,000,000 · Filed 2017-05-17 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $500,000 · Remaining $90,300,000 · Duration One year or less · Commission $4,400,000 · Revenue Not Applicable | ||||
| VC | Clarus IV-C LP | [2018-03-28] | 789.7 M | 257.5 M |
| Offered $880,000,000 · Filed 2017-05-17 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $250,000 · Remaining $90,300,000 · Duration One year or less · Commission $4,400,000 · Revenue Not Applicable | ||||
| VC | Clarus IV-D LP | [2018-03-28] | 789.7 M | 51.4 M |
| Offered $880,000,000 · Filed 2017-05-17 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $7,700,000 · Remaining $90,300,000 · Duration One year or less · Commission $4,400,000 · Revenue Not Applicable | ||||
| VC | Clarus Defined Exit I LP | [2015-03-23] | 100.0 M | 63.9 M |
| Offered $100,000,000 · Filed 2014-08-05 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $14,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Clarus de II LP | [2015-03-23] | 40.0 M | 26.8 M |
| Offered $40,000,000 · Filed 2014-09-18 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $40,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Clarus Lifesciences III LP | [2015-03-23] | 234.2 M | 24.8 M |
| Offered $375,000,000 · Filed 2014-06-19 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $140,840,000 · Duration One year or less · Revenue Not Applicable | ||||
| VC | Clarus Lifesciences II LP | [2012-03-22] | 23.8 M | |
| VC | Clarus Lifesciences I LP | 2012-03-22 | 0.5 M | |
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 9 | 0.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 9 | 0.8 |
| By Discretionary | ||
| Discretionary | 9 | 0.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 9 | 0.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.8 | |
| Total | 9 | 0.8 |
| Limited Partners | 2011 - 2026 |
|---|---|
| California Public Employees' Retirement System | |
| New York State Common Retirement Fund |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Nicholas Galakatos | Executive Officer | 53 | 3 | |
| Robert Liptak | Executive Officer | 23 | 3 | |
| Kurt Wheeler | Executive Officer | 25 | 2 | |
| Scott Requadt | Executive Officer | 21 | 2 | |
| Dennis Henner | Executive Officer | 17 | 2 | |
| Emmett Cunningham | Executive Officer | 14 | 2 | |
| Nicholas Simon | Executive Officer | 12 | 2 | |
| Clarus Ventures III LLC | Director | 2 | 2 | |
| Clarus IV GP LP | Director | 4 | 1 | |
| Clarus IV GP LLC | Director | 4 | 1 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001431431] | |
| 13F-NT | [0001431431] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| LEI | 9845004AEBAE1D8C4E60 |
| Related Firms | State | AUM |
|---|---|---|
|
Blackstone Life Sciences Advisors LLC
✚
|
MA | 13.19 B |
|
Clarus Ventures LLC
✚
|
MA | 805.6 M |
| Comparable Firms | State | AUM |
|---|---|---|
|
American Ventures IM LLC
✚
|
FL | 813.7 M |
|
Sunflower Wealth Advisors LLC
✚
|
KS | 812.8 M |
|
Horizon Technology Finance Management LLC
✚
|
CT | 811.1 M |
|
EFG Asset Management North America Corp
✚
|
OR | 808.9 M |
|
Polen Capital CLO Management LLC
✚
|
MA | 808.4 M |
|
OHA Private Credit Advisors II LP
✚
|
NY | 805.2 M |
|
Fintech Collective Management LLC
✚
|
NY | 800.8 M |
|
ICR Partners LLC
✚
|
TN | 798.7 M |
|
337 Frontier Capital LP
✚
|
NY | 795.3 M |
|
Friends & Family Capital Management LLC
✚
|
CA | 793.8 M |